Alaunos Therapeutics (TCRT) EBIT Margin (2011 - 2025)
Alaunos Therapeutics' EBIT Margin was -30233.33% in Q4 2025, down 11358.33 percentage points from -18875.00% a year earlier.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) EBIT Margin (2011 - 2025) Analysis & Trends
For FY2025, EBIT Margin at Alaunos Therapeutics came in at -84500.00%, down 36380.00 percentage points from FY2024.
- EBIT Margin shows a four-year change of -65112.75 percentage points (FY2021 to FY2025).
- In earlier years, EBIT Margin was -48120.00% in FY2024 (+637220.00 pp), -685340.00% in FY2023 (-684138.60 pp), -1201.40% in FY2022 (+18185.85 pp) and -19387.25% in FY2021.
- Quarterly EBIT Margin has moved between -794900.00% (Q4 2023) and -283.89% (Q3 2022) over five years.
- Compared with a year earlier, EBIT Margin was higher in three of the last four quarters, with an average year-over-year change of +263666.67 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Alaunos Therapeutics | 2.39 Mn | -1.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -30,233.33% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -18,875.00% |
| Jun 30, 2024 | -29,150.00% |
| Mar 31, 2024 | -174,200.00% |
| Dec 31, 2023 | -794,900.00% |
| Jun 30, 2023 | -199,550.00% |
| Dec 31, 2022 | -77,463.64% |
| Sep 30, 2022 | -283.89% |
| Dec 31, 2021 | -552,550.00% |
| Sep 30, 2021 | -5,602.01% |
| Mar 31, 2018 | -11,093.15% |
| Dec 31, 2017 | -841.33% |
| Sep 30, 2017 | -818.40% |
| Jun 30, 2017 | -814.90% |
| Mar 31, 2017 | -874.45% |
| Dec 31, 2016 | -695.74% |
| Sep 30, 2016 | -682.98% |
| Jun 30, 2016 | -7,733.77% |
| Mar 31, 2016 | -611.48% |
API Access
Alaunos Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();